• A clinical leadership & management training programme for senior trainees with an interest in Cystic Fibrosis, Cheisi Connect. Birmingham, UK, 5th-6th December 2022. Invited Speaker – “Getting ready to apply for a consultant role, preparing your CV, interview preparation”
• 21st Polish Cystic Fibrosis Society Conference. Pabianice, Poland, 21st of October 2022. Invited Speaker: “Clinical responses to CFTR modulator therapy”.
• 40th Congress of the Brazilian Respiratory Society. Campinas, Brazil 13th of October 2022. Invited Speaker “New Perspectives with Triple Combination CFTRm Therapy for Cystic Fibrosis.”
• 45th European Cystic Fibrosis Society (ECFS) Conference. Rotterdam 9th of June 2022. Invited Speaker as part of “Patient Outcomes: What counts and what can be counted”
• 45th European Cystic Fibrosis Society (ECFS) Conference. Rotterdam 9th of June 2022. Invited Speaker as part of “What is a positive response in CFTR Modulators”
• Association of Chartered Physiotherapists in CF (ACPCF) Non Medical Prescribers Group (NMP) Autumn Meeting. [online] 27th May 2022. Invited Speaker “Inhaled Therapies in an era of CFTR modulators”.
• Boston Scientific “The Bronchoscopy Expert Meeting” 4th of May 2022. Invited as an Expert Attendee- Advising.
• Royal College of Physicians Infectious Disease SpR CUH Study Day. Cork 29th of April 2022. Invited Speaker. “Airway infection in Cystic Fibrosis”
• Tralee GPs Continuous Medical Education Seminar. Kerry 27th of April 2022. Invited & Lead Speaker. “New opportunities for COPD using triple therapy in an ever changing healthcare environment”
• Cystic Fibrosis Association Ireland Conference 2022. [online] 30th March 2022. Key Note Speaker “Inhaled Therapies in an era of CFTR Modulars”.
• Pfizer Virtual med Café Session. Cystic Fibrosis in a changing world [online] 10th March 2022. Chair Person.
• European Respiratory Society (ERS). Online Course Virtual school on cystic fibrosis [online] 21st January 2022. Session Chair for Session2: Infection, Introduction Presentation titled “Airway infection in CF”& Panel Discussion.
• Global Congress on Cystic Fibrosis 2021. Future of CF Treatments and Management Plans. [online] 10th December 2021. Invited Speaker “Future CF care; CFTR modulators and beyond”
• Vertex Regional CF Exceed Educational Meeting, Updates and special topics in Cystic Fibrosis management, [online] 27th of October 2021. Invited Speaker “Updates in Cystic Fibrosis Management”
• National Congress of the Italian Society for the Study of Cystic Fibrosis, 21st of October 2021. Invited Speaker in session Integrative microbiomics: a paradigm shift to understanding pulmonary infection?: “The extrapulmonary effect of CFTR modulator therapy”
• National Quality, Clinical Risk & Patient Safety Webinar Series, [online] 30th of September 2021. Invited Speaker “TeCC (Telemedicine, Coronavirus, Cystic-fibrosis) Talk experiences from Cork University hospital”
• European Respiratory Society International Congress 2021, [online] 6th September 2021. Session Chair: “Adult Cystic Fibrosis”
• 2nd European NTM & Bronchiectasis Workshop, [online] 30th June – 3rd July 2021. Invited Speaker: “The extrapulmonary effect of CFTR Modulator Therapy”
• European Cystic Fibrosis Society (ECFS) Conference, [online] 10th of June 2021. Invited Speaker as part of “Is Virtual Monitoring the way forward in CF care: Pro”
• Health Information and Quality Authority (HIQA) [online] DATE. Invited Speaker “TeCC (Telemedicine, Coronavirus, Cystic-fibrosis) Talk experiences from Cork University hospital”
• IEHG National grand Rounds, Virtual 31st of April 2021. Invited Speaker. “Patient Background”.
• Global Congress on Cystic Fibrosis 2021. Future of CF Treatments and Management Plans. [online] 10th December 2021. Invited Speaker “Future CF care; CFTR modulators and beyond”
• Vertex Regional CF Exceed Educational Meeting, Updates and special topics in Cystic Fibrosis management, [online] 27th of October 2021. Invited Speaker “Updates in Cystic Fibrosis Management”
• National Congress of the Italian Society for the Study of Cystic Fibrosis, 21st of October 2021. Invited Speaker in session Integrative microbiomics: a paradigm shift to understanding pulmonary infection?: “The extrapulmonary effect of CFTR modulator therapy”
• National Quality, Clinical Risk & Patient Safety Webinar Series, [online] 30th of September 2021. Invited Speaker “TeCC (Telemedicine, Coronavirus, Cystic-fibrosis) Talk experiences from Cork University hospital”
• European Respiratory Society International Congress 2021, [online] 6th September 2021. Session Chair: “Adult Cystic Fibrosis”
• 2nd European NTM & Bronchiectasis Workshop, [online] 30th June – 3rd July 2021. Invited Speaker: “The extrapulmonary effect of CFTR Modulator Therapy”
• European Cystic Fibrosis Society (ECFS) Conference, [online] 10th of June 2021. Invited Speaker as part of “Is Virtual Monitoring the way forward in CF care: Pro”
• Health Information and Quality Authority (HIQA) [online] DATE. Invited Speaker “TeCC (Telemedicine, Coronavirus, Cystic-fibrosis) Talk experiences from Cork University hospital”
• IEHG National grand Rounds, Virtual 31st of April 2021. Invited Speaker. “Patient Background”.
• eHealth Ireland, Video Enabled Care Webinars, 21st of October 2020. Invited Speaker. “Webinar 9: Exploring different ways of working in video enabled care Cystic Fibrosis based in Cork University Hospital”: https://www.ehealthireland.ie/National-Virtual-Health-Team/Video-Enabled-Care-Webinars/
• LEAD Telemedicine webinar series: State-of-the-art: virtual clinics and home spirometry, [online] 11th November 2020. Invited Speaker. “Accelerated implementation of TeleMedicine”
• European Respiratory Society (ERS) 2020 International Congress. [online] September 2020. Invited Speaker. “Gastrointestinal issues in cystic fibrosis and their relevance to the lungs”
• European Cystic Fibrosis Society (ECFS) Conference, [online] 25th of September 2020. Invited Speaker as part of Current & future strategies in an evolving Cystic Fibrosis treatment landscape Moderator workshop. “The future of antibiotics in an era of new therapies in cystic fibrosis”
• European Cystic Fibrosis Society (ECFS) Conference, [online] 24th of September 2020. Invited Speaker as part of The journey ahead: Reimagining the future of cystic fibrosis in an era of precision therapies workshop. “Rethinking care for an ageing community
• LEAD Covid-19 and CF management virtual series. June 2020. [online] Invited Speaker. Webinar 3 “How to create stability in a time of instability”
•Trinity Postgraduate Respiratory Conference, Dublin, 25th of October 2019. Invited Speaker. “Update on Cystic Fibrosis”.
•Irish Molecular Diagnostic Annual Scientific Meeting, Dublin, 4th of October 2019. Invited Speaker. “Latest in CF Research”.
•1st Adult Cystic Fibrosis Conference, Milan Italy, 6th September 2019. Invited Speaker. “Management of Infections, Adults are Different”.
•42nd European Cystic Fibrosis Conference, Liverpool, 7th June 2019. Symposium 01. “Dilemmas in CFTR modulators. Is lung function the only player in town?”.
•3 May 2019, Speaker Brazilian CF Congress CFTR Modulation: review of clinical data and real-world evidence with clinical outcomes, Brazil
•The 19th Killarney National Cystic Fibrosis Clinical Meeting, February 2019. CFTR Modulators.
•5-6 October 2018, Speaker CF EXCEED Recent updates in CF management, CF Infection Control: from buildings to bacteria and Evolving multisystemic issues in CF, Oman
•24-25 September 2018, Vertex Moderator Roundtable, Italy
•UK Cystic Fibrosis Conference, 10th September 2018, “CF MATTERS - Comparing the use of microbiome-directed antibiotic treatment versus standard therapy for patients with CF experiencing respiratory infections.” https://player.vimeo.com/video/289773531
•Australian Speaker Tour (2 talks per day), 13th-17th August 2018, Australia, Sydney, Brisbane, Melbourne, Adelaide, Perth. Title of talk 1: “CFTR Modulator Therapy Updates”. Title of talk 2: “CFMATTERS Updates”.
•Australian CF Nurses Annual Scientific Conference, Sydney 9th of Aug 2018. Plenary Speaker. Practical approaches to CF challenges.
•41st European Cystic Fibrosis Conference, Belgrade 8th June 2018. Satellite symposium Vertex. “Shifting the paradigm in cystic fibrosis management: current and future perspectives. Future thinking: assessing effectiveness in practice”.
•41st European Cystic Fibrosis Conference, Belgrade 7th June 2018. Symposium 01. “Microbiome directed treatment”.
•11 May 2018, Speaker Current practices in adult CF management, Oman
•The 18th Killarney National Cystic Fibrosis Clinical Meeting, February 2018. Using the CF Microbiome to Inform the Treatment of Pulmonary Exacerbations - CFMATTERS...Or Does It?
•19-20 October 2017, Speaker and Chair Cork CF GUIDE, Ireland
•The three rules of technologies in lung disease- Douglas Adams got it right!. September 2017. Respiratory Grand Rounds at the Royal Brompton Hospital
•Virtual Reality Experiences, mHealth and eLearning for lung diseases: the present, not the future. April 2017. Grand Rounds at Cork University Hospital
•17 November 2017, Speaker CF EXCEED Multisystemic Nature of CF: which organ systems and how are they impacted at different ages and Progressive Lung disease in Adult patients – managing the decline, Romania
•31st Annual north American Cystic Fibrosis Conference, 4th of November 2017. Invited Speaker. “CFMATTERS? Or does it?”.
•13 July 2017, Payer Advisory Board Tezacaftor/Ivacaftor, UK
•40th European Cystic Fibrosis Conference, Seville 10th June 2017. Symposium 07. “Using CF microbiota analysis to inform treatment of respiratory infection: are we there yet?”.
•5-6 May 2017, Speaker CF EXCEED Multisystemic Nature of CF: which organ systems and how are they impacted at different ages and Progressive Lung disease in Adult patients – managing the decline, Dubai, UAE
•Wellcome Genome Campus conference on Exploring Human Host-Microbiome Interactions in Health and Disease, 8th September 2016. Invited Plenary Speaker. “Microbiome in Chronic Conditions”.
•Medscape Education Pulmonary Medicine, 2016. Filmed Panel Discussion. "Experts discuss the optimal use of inhaled antibiotics alongside CFTR modulators in treating chronic airway infection in CF". http://www.medscape.org/viewarticle/870572
•Speaker and Chair Cork CF GUIDE meeting, Ireland, 22-23 September 2016,
•Speaker Practical Experience with CFTR Modulation and Kalydeco long-term experience, Switzerland, 15 September 2016.
•39th European Cystic Fibrosis Conference, Basil 10th June 2016. Satellite symposium – Office of continuing Medical Education. “Long-term post-approval data for CFTR modulators”.
•26 May 2016, Speaker Orkambi clinical data and the practical application of Orkambi in the clinical setting, Ireland
•20-21 May 2016, Speaker New Perspectives – C. difficile in CF and the CF gut microbiome, CF Perspectives Masterclass, Sweden
•17 February 2016, Meeting to develop peer to peer slide deck on Lumacaftor/Ivacaftor
•The 16th Killarney National Cystic Fibrosis Clinical Meeting, February 2016. Attitudes to Reproductive Health and Contraception.
•29th Annual North American Cystic Fibrosis Conference, 8th of October 2015. Invited Symposium Speaker. “Clostridium Difficile & Other Gut Infections in Patients with Pulmonary Disease Including CF”
•European Respiratory Society International Congress Meeting - Education and Scientific session, 26th September 2015. Invited hot Topics Speakers. "Comorbidities in cystic fibrosis".
•Oman Thoracic Society Annual scientific conferences, Oman, 19th September 2015. Muscat Airway Symposium. “CF, An overview of diagnosis and complications with aging”.
•Oman Thoracic Society Annual scientific conferences, Oman, 19th September 2015. Muscat Airway Symposium. “CF, Transition from Childhood to Adulthood”.
•11th Australasian Cystic Fibrosis Conference, Sydney, 18th August 2015. Closing Plenary. “CFTR modulation, who benefits most? Clinical efficacy and real-world effectiveness”
•11th Australasian Cystic Fibrosis Conference, Sydney, 18th August 2015. Symposium. “Ivacaftor Beyond the Lungs”
•11th Australasian Cystic Fibrosis Conference, Sydney, 18th August 2015. Symposium. “Adherence, Treatment Satisfaction and Real World Data For Dry Powder Tobramycin”
•11th Australasian Cystic Fibrosis Conference, Sydney, 16th August 2015. Panel Discussion. “The real costs of Cystic Fibrosis”
•11th Australasian Cystic Fibrosis Conference, Sydney, 16th August 2015. Keynote Address. “Evolution of CF management and what the future holds?”
•Expert viewpoints in cystic fibrosis. 24th June 2015. Royal College of Physicians of Ireland, Dublin. Speaker and Chair. “Inhaled Antibiotics: Trials, Practicalities and Challenges”.
•38th European Cystic Fibrosis Conference, Brussels 13th June 2015. Symposium 26. “Managing exacerbations - Interactive debates”.
•38th European Cystic Fibrosis Conference, Brussels 11th June 2015. Symposium 01. “CFTR Modulation in real life, Efficacy: who benefits most?”.
•38th European Cystic Fibrosis Conference, Brussels 11th June 2015. Special Symposium 01. “Research Opportunities in EU, CFMATTERS”.
•24 April 2015, Speaker at an educational workshop at 5th Brazilian CF Conference, Brazil
•15 March 2014, Symposium Speaker, Gulf Thoracic Conference, Dubai
•37th European Cystic Fibrosis Conference, Gothenburg 13th June 2014. Symposium 19. “Airway controversies”.
•37th European Cystic Fibrosis Conference, Gothenburg 12th June 2014. Satellite Symposium. “Changing faces, changing guidelines”.
•37th European Cystic Fibrosis Conference, Gothenburg 12th June 2014. Workshop 07. “Abstract 470: Inhaled Aztreonam Lysine (Cayston) Therapy significantly improves lung function, weight, hospitalisations and exacerbation rates prospectively – an Irish and UK real world experience”.
•Brazilian CF Association, Sao Paulo Brazil, 5th of April 2014. Invited Plenary Speaker. “Why TIP can improve adherence in CF”.
•Invited Speaker Tour. Canada: Vancouver, Calgarry, Edmonton, Montreal, Ottowa, Torronto. 17th – 21st March 2014. “Emerging Treatments and Strategies an Irish Perspective”.
•APC Research Symposium - “Scientific Advisory Board meeting”, Cork, 16th October 2014. “CFMATTERS”
•Expert viewpoints in cystic fibrosis. 19th September 2014. Royal College of Physicians of Ireland, Dublin. Speaker and Chair. “Future planning of CF services: the role of the clinician, the charities and government agencies”.
•3rd National Conference in Paediatric Pulmonology & 1st National CF Conference, Guadalajara Mexico, July 2013. Invited Plenary. “Use of inhaled antibiotics in CF”.
•APC CSET2 Close-out Site SFI Review, Cork 5th December 2013. “CFMATTERS”.
•Invited Speaker Tour (2 talks per day). Australia: Brisbane, Sydney, Melbourne, 18th -22nd November 2013. “Updates on CFTR Modulation – the Cork Experience” and talk 2 “CFMATTERS”.
•Expert viewpoints in cystic fibrosis. July 3rd 2013. Royal College of Physicians of Ireland, Dublin. “Ageing in CF”. https://expertviewpoints.org/index.php
•APC Launch Symposium, June 21st 2013. Boole Health Sciences Complex. UCC. Cork. “CFMATTERS a microbial perspective!”.
•36th European Cystic Fibrosis Conference Lisbon, Portugal 13th June 2013. Changing Faces, changing guidelines- Lunchtime symposium. “Overview. Changing Faces, changing guidelines”.
•36th European Cystic Fibrosis Conference Lisbon, Portugal 13th June 2013. Satellite symposium. “Paving the way for a brighter future”.
•36th European Cystic Fibrosis Conference Lisbon, Portugal 13th June 2013.Ivacaftor: Paving the Way for a Brighter Future for Patients. Evening symposium. “Clinical cases- The Irish Perspective”.
•Respiratory Medicine. A Practical Approach- Current Treatments and Innovations. Saturday 20th April 2013. The Radisson Hotel, Cork. “Smoking cessation strategies”.
•Irish College of General Practitioners – East Cork Faculty meeting 7th April 2013. “Up- dates on Cystic Fibrosis for the generalist”.
•Symposium medicines CF. March 22nd 2013 Lausanne, Switzerland. Invited Plenary speaker at National Swiss CF meeting. “Long-term complications of Aging in CF”.
•Spanish Cystic Fibrosis Symposium. Madrid. March 8th & 9th 2013. “Adherence and efficacy of inhaled antibiotic in CF.”
•Dutch National CF symposium – Utrecht March 1st 2013. “Emerging topics with ageing in CF”.
•Lunchtime Learning Lounge series. Smoking Cessation 2013- February 2013. What the healthcare professional needs to know. Webinar CME accredited. www.pfizerwebinar.ie
•The 13th Killarney National Cystic Fibrosis Clinical Meeting, February 2013. Adult Case Report